Skip to content

Clinical Evaluation of the Levita Robotic Platform

Clinical Evaluation of the Levita Robotic Platform

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05353777
Enrollment
48
Registered
2022-04-29
Start date
2021-05-15
Completion date
2022-08-29
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Cholelithiases, Other Disease

Brief summary

The purpose of this study is to evaluate the safety and feasibility of the Levita Robotic Platform (LRP) used with the Levita Magnetic Surgical System (MSS)

Detailed description

Prospective, multi-center, single-arm, open label study designed to assess the safety and feasibility of the use of the Levita Robotic Platform with the Levita Magnetic Surgical System in laparoscopic procedures.

Interventions

DEVICELevita Robotic Platform

Levita Robotic Platform

Sponsors

The Cleveland Clinic
CollaboratorOTHER
Levita Magnetics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Subject is at least 18 years of age * Subject is scheduled to undergo elective laparoscopic procedure * Subject signs a written Informed Consent Form (ICF) to participate in the study prior to any study required procedures

Exclusion criteria

* • Subjects with pacemakers, defibrillators, or other electromedical implants * Subjects with ferromagnetic implants * Subjects with significant comorbidities: cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure) * Subjects with a clinical history of impaired coagulation confirmed by abnormal blood tests * Subject has an anatomical abnormality or disease of intended target tissue noted after initiation of index procedure that would prevent device use * Subject is pregnant or wishes to become pregnant during the length of study participation * Subject is not likely to comply with the follow-up evaluation schedule * Subject is participating in a clinical trial of another investigational drug or device

Design outcomes

Primary

MeasureTime frameDescription
Adverse Events Related to the Device30 daysTotal number of adverse events related to the device.

Secondary

MeasureTime frameDescription
Rate That the Levita Robotic Platform is Able to Engage, Move, and Decouple With the Magnetic Surgical System as Controlled by the SurgeonInteroperativelyNumber of successfully performed surgeries without the need of additional tools.
Conversion Rate to Open SurgeryInteroperativelyConversion from laparoscopic to open surgery due to inability of the robotic system to provide adequate visualization.

Countries

Chile

Participant flow

Participants by arm

ArmCount
Levita Robotic Platform
Levita Robotic Platform: Levita Robotic Platform
46
Total46

Baseline characteristics

CharacteristicLevita Robotic Platform
Age, Continuous45 years
STANDARD_DEVIATION 13.25
Ethnicity (NIH/OMB)
Hispanic or Latino
46 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Region of Enrollment
Chile
46 participants
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 46
other
Total, other adverse events
15 / 46
serious
Total, serious adverse events
1 / 46

Outcome results

Primary

Adverse Events Related to the Device

Total number of adverse events related to the device.

Time frame: 30 days

ArmMeasureValue (NUMBER)
Levita Robotic PlatformAdverse Events Related to the Device3 Adverse events related to device
Secondary

Conversion Rate to Open Surgery

Conversion from laparoscopic to open surgery due to inability of the robotic system to provide adequate visualization.

Time frame: Interoperatively

ArmMeasureValue (NUMBER)
Levita Robotic PlatformConversion Rate to Open Surgery0 Converted procedures
Secondary

Rate That the Levita Robotic Platform is Able to Engage, Move, and Decouple With the Magnetic Surgical System as Controlled by the Surgeon

Number of successfully performed surgeries without the need of additional tools.

Time frame: Interoperatively

ArmMeasureValue (NUMBER)
Levita Robotic PlatformRate That the Levita Robotic Platform is Able to Engage, Move, and Decouple With the Magnetic Surgical System as Controlled by the Surgeon46 Successfully performed surgeries

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026